SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BONDANELLI, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.363
AS - Asia 7.123
EU - Europa 4.782
SA - Sud America 1.092
AF - Africa 154
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 24.531
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.031
SG - Singapore 2.704
CN - Cina 1.805
DE - Germania 1.454
BR - Brasile 868
IT - Italia 829
VN - Vietnam 730
UA - Ucraina 693
HK - Hong Kong 593
GB - Regno Unito 373
RU - Federazione Russa 344
TR - Turchia 335
FI - Finlandia 289
FR - Francia 261
BD - Bangladesh 246
JP - Giappone 181
PL - Polonia 159
IN - India 146
CA - Canada 145
SE - Svezia 141
MX - Messico 132
AR - Argentina 78
ID - Indonesia 74
IQ - Iraq 58
NL - Olanda 58
ZA - Sudafrica 56
PK - Pakistan 49
EC - Ecuador 43
ES - Italia 38
VE - Venezuela 30
BE - Belgio 25
CO - Colombia 23
SA - Arabia Saudita 22
MY - Malesia 21
LT - Lituania 20
UZ - Uzbekistan 20
MA - Marocco 19
TN - Tunisia 19
AE - Emirati Arabi Uniti 17
PH - Filippine 17
AT - Austria 16
CL - Cile 16
AU - Australia 12
IE - Irlanda 11
JM - Giamaica 11
JO - Giordania 11
AL - Albania 10
BO - Bolivia 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
DZ - Algeria 9
TH - Thailandia 9
DK - Danimarca 8
EG - Egitto 8
KE - Kenya 8
LB - Libano 8
PA - Panama 8
PS - Palestinian Territory 8
AZ - Azerbaigian 7
ET - Etiopia 7
IL - Israele 7
KR - Corea 7
KZ - Kazakistan 7
UY - Uruguay 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
PE - Perù 6
RO - Romania 6
KG - Kirghizistan 5
NP - Nepal 5
TT - Trinidad e Tobago 5
BB - Barbados 4
CY - Cipro 4
GA - Gabon 4
HN - Honduras 4
IR - Iran 4
LV - Lettonia 4
NG - Nigeria 4
NI - Nicaragua 4
AO - Angola 3
BF - Burkina Faso 3
BG - Bulgaria 3
BH - Bahrain 3
CR - Costa Rica 3
GR - Grecia 3
HU - Ungheria 3
PT - Portogallo 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TZ - Tanzania 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
EU - Europa 2
GT - Guatemala 2
KH - Cambogia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MD - Moldavia 2
Totale 24.495
Salva come PNG Salva come JPEG
Città #
Singapore 1.721
Ashburn 1.283
San Jose 920
Woodbridge 905
Chandler 722
Jacksonville 680
Fairfield 604
Hong Kong 582
Santa Clara 577
Beijing 575
Houston 418
Ann Arbor 342
Wilmington 278
New York 266
Ho Chi Minh City 242
Seattle 221
Los Angeles 220
Izmir 207
Nanjing 203
Addison 202
Cambridge 183
Munich 176
Hanoi 172
Tokyo 171
Dallas 170
Princeton 155
Warsaw 152
Lauterbourg 139
Milan 130
Helsinki 111
San Diego 97
São Paulo 90
Shanghai 89
Mexico City 79
Council Bluffs 76
Shenyang 70
Boardman 66
Ferrara 65
Orem 57
Hebei 56
Hefei 55
Buffalo 51
Dearborn 50
London 50
Montreal 50
Turku 47
Nanchang 46
Tianjin 45
Chicago 41
Chennai 40
Bremen 39
Changsha 38
Haiphong 38
Jakarta 37
Rome 37
Denver 35
Brooklyn 34
Phoenix 34
Toronto 34
Moscow 31
Bologna 30
Jiaxing 30
Johannesburg 30
San Francisco 30
Manchester 29
Poplar 29
Stockholm 29
Da Nang 28
Kunming 27
Washington 27
Atlanta 25
Baghdad 25
Falls Church 25
Frankfurt am Main 25
Boston 24
Brussels 24
Jinan 24
Redwood City 24
Rio de Janeiro 24
Mountain View 23
Mumbai 22
Hải Dương 21
Norwalk 21
Quito 21
Amsterdam 20
Lahore 20
Belo Horizonte 19
Zhengzhou 19
Guangzhou 18
Curitiba 17
Tashkent 17
Ankara 16
Falkenstein 16
Brasília 15
Campinas 15
Ningbo 15
Dhaka 14
Modena 14
Naples 14
San Mateo 14
Totale 15.184
Salva come PNG Salva come JPEG
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 324
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 264
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 254
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 253
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 241
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 240
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 235
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 226
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 224
Acromegaly is associated with increased cancer risk: a survey in Italy 220
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 218
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 218
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 213
Growth hormone excess promotes breast cancer chemoresistance 211
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 207
Antiproliferative effects of somatostatin analogs in pituitary adenomas 202
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 202
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 202
Diurnal rhythm of plasma catecholamines in acromegaly 200
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 197
L’iperplasia surrenale congenita e la pubertà precoce 194
A new VHL polymorphism in a big family from Ferrara 193
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 191
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 188
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 187
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 186
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 185
Glucose metabolism alterations in acromegaly 184
Pituitary side effects of old and new drugs. 184
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 182
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 182
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 181
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 180
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 179
In vitro testing of new somatostatin analogs on pituitary tumor cells 178
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 177
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 177
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 177
Cerebral aneurysm and acromegaly: a case report 176
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 176
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 176
ASSE GH-IGF-I NELL'INVECCHIAMENTO 174
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 173
Role of the serotonergic system in the genesis of vasovagal syncope 172
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 172
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 172
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 171
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 170
Functional hypothalamic and drug-induced amenorrhea: an overview 170
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 168
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study 168
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 168
Effects of pasireotide on bronchial carcinoids in primary culture 168
Le alterazioni pressorie nell'acromegalia: fattori umorali 168
Delta opioid receptor involvement in endocrine pathophysiology 165
Sistema Simpatoadrenomidollare nei pazienti acromegalici 165
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 164
PATOLOGIA CEREBRALE ACQUISITA ED IPOPITUITARISMO 161
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 161
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 161
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 161
Cerebrovascular disease and GH-IGF-i axis function 160
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 160
Replacement therapy and quality of life improvement in adult GHD patients 158
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 157
Inflammatory cytokines and neurotrophic factors correlate with pituitary function after stroke 157
Acromegaly in the elderly patients 156
Bone metastases frequency, distribution, clinical and imaging characteristics in neuroendocrine tumors: our experience 155
Predictors of morbidity and mortality in acromegaly: An Italian survey 154
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 154
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 153
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 152
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review 151
Efficay and safety of teriparatide treatment 151
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 149
Follow-up dei pazienti sottoposti a terapia chirurgica per adenomi ipofisari non secernenti. 149
Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation. 148
Prevalence of hypopituitarismin patients with cerebrovascular diseases 147
Clinica e diagnostica dei tumori neuroendocrini 147
GH/IGF-1 axis in a large cohort of ss-thalassemia major adult patients: a cross-sectional study 147
Human galanin reduces plasma norepinephrine levels in man 146
Role of GH-IGF-1 excess on periodontal tissues 146
Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy 145
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 144
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 144
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter? 144
Craniopharyngioma and Eating Disorders 141
Systemic illness 139
INVECCHIAMENTO E GH 139
Differential effects of deltorphin on arginine and galanin-induced growth hormone secretion in healthy man. 139
Successful treatment with everolimus of functioning liver metastases from a pancreatic insulinoma 139
RELIABILITY OF QUANTITATIVE ULTRASOUND IN THE FOLLOW-UP OF ADULTS WITH GH DEFICIENCY UNDERGOING REPLACEMENT THERAPY 137
Long-term low-dose tolvaptan efficacy and safety in SIADH 136
La terapia dei tumori neuroendocrini. 136
Tumori neuroendocrini: i meccanismi fisiopatologici 135
BENEFICIAL EFFECT OF GH REPLACEMENT ON COGNITIVE FUNCTIONING IN A PATIENT WITH POST-TRAUMATIC HYPOPITUITARISM 135
Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation 134
Occurrence of pituitary dysfunction following traumatic brain injury 134
FISIOPATOLOGIA, CLASSIFICAZIONE, PATOGENESI (ACROMEGALIA) 133
GH-IGF-I deficit 133
Totale 17.420
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 14.503
Totale 123.718
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 0 0 67
2021/20221.387 36 139 90 60 55 58 48 61 42 120 118 560
2022/20231.527 155 136 52 203 207 230 74 114 214 16 69 57
2023/2024834 68 95 50 25 51 176 25 79 25 24 24 192
2024/20253.452 99 76 267 106 419 359 129 131 579 428 483 376
2025/202610.028 939 384 800 1.162 1.615 631 1.178 535 892 1.140 479 273
Totale 24.727